These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15888668)

  • 1. Induction of hepatic peroxisome proliferation by 8-2 telomer alcohol feeding in mice: formation of perfluorooctanoic acid in the liver.
    Kudo N; Iwase Y; Okayachi H; Yamakawa Y; Kawashima Y
    Toxicol Sci; 2005 Aug; 86(2):231-8. PubMed ID: 15888668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels.
    Kawashima Y; Kobayashi H; Miura H; Kozuka H
    Toxicology; 1995 May; 99(3):169-78. PubMed ID: 7610463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of the liver to perfluorinated fatty acids with different carbon chain length in male and female mice:in relation to induction of hepatomegaly, peroxisomal beta-oxidation and microsomal 1-acylglycerophosphocholine acyltransferase.
    Kudo N; Suzuki-Nakajima E; Mitsumoto A; Kawashima Y
    Biol Pharm Bull; 2006 Sep; 29(9):1952-7. PubMed ID: 16946516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction by perfluorinated fatty acids with different carbon chain length of peroxisomal beta-oxidation in the liver of rats.
    Kudo N; Bandai N; Suzuki E; Katakura M; Kawashima Y
    Chem Biol Interact; 2000 Jan; 124(2):119-32. PubMed ID: 10670823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisomal enzymes and 8-hydroxydeoxyguanosine in rat liver treated with perfluorooctanoic acid.
    Abdellatif A; Al-Tonsy AH; Awad ME; Roberfroid M; Khan MN
    Dis Markers; 2003-2004; 19(1):19-25. PubMed ID: 14757943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of urinary metabolite excretion after rat acute exposure to perfluorooctanoic acid and other peroxisomal proliferators.
    Rigden M; Pelletier G; Poon R; Zhu J; Auray-Blais C; Gagnon R; Kubwabo C; Kosarac I; Lalonde K; Cakmak S; Xiao B; Leingartner K; Ku KL; Bose R; Jiao J
    Arch Environ Contam Toxicol; 2015 Jan; 68(1):148-58. PubMed ID: 25015730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerobic biotransformation of 14C-labeled 8-2 telomer B alcohol by activated sludge from a domestic sewage treatment plant.
    Wang N; Szostek B; Folsom PW; Sulecki LM; Capka V; Buck RC; Berti WR; Gannon JT
    Environ Sci Technol; 2005 Jan; 39(2):531-8. PubMed ID: 15707053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice.
    Xie Y; Yang Q; Nelson BD; DePierre JW
    Biochem Pharmacol; 2003 Sep; 66(5):749-56. PubMed ID: 12948855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and phenotypic responses of male crucian carp (Carassius auratus) exposed to perfluorooctanoic acid.
    Dong H; Lu G; Yan Z; Liu J; Ji Y
    Sci Total Environ; 2019 Feb; 653():1395-1406. PubMed ID: 30759578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis.
    Berthiaume J; Wallace KB
    Toxicol Lett; 2002 Mar; 129(1-2):23-32. PubMed ID: 11879971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice.
    Yang Q; Xie Y; Eriksson AM; Nelson BD; DePierre JW
    Biochem Pharmacol; 2001 Oct; 62(8):1133-40. PubMed ID: 11597582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative hepatic effects of perfluorooctanoic acid and WY 14,643 in PPAR-alpha knockout and wild-type mice.
    Wolf DC; Moore T; Abbott BD; Rosen MB; Das KP; Zehr RD; Lindstrom AB; Strynar MJ; Lau C
    Toxicol Pathol; 2008 Jun; 36(4):632-9. PubMed ID: 18467680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic peroxisome proliferation in vitamin A-deficient mice without a simultaneous increase in peroxisomal acyl-CoA oxidase activity.
    Sohlenius AK; Reinfeldt M; Bäckström K; Bergstrand A; DePierre JW
    Biochem Pharmacol; 1996 Mar; 51(6):821-7. PubMed ID: 8602878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorooctanoic acid induces peroxisomal fatty acid oxidation and cytokine expression in the liver of male Japanese medaka (Oryzias latipes).
    Yang JH
    Chemosphere; 2010 Sep; 81(4):548-52. PubMed ID: 20594573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships and human relevance for perfluoroalkyl acid-induced transcriptional activation of peroxisome proliferation in liver cell cultures.
    Bjork JA; Wallace KB
    Toxicol Sci; 2009 Sep; 111(1):89-99. PubMed ID: 19407336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats.
    Takagi A; Sai K; Umemura T; Hasegawa R; Kurokawa Y
    Cancer Lett; 1991 Apr; 57(1):55-60. PubMed ID: 2025879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorooctanoic acid and perfluorononanoic acid in fetal and neonatal mice following in utero exposure to 8-2 fluorotelomer alcohol.
    Henderson WM; Smith MA
    Toxicol Sci; 2007 Feb; 95(2):452-61. PubMed ID: 17093205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout.
    Tilton SC; Orner GA; Benninghoff AD; Carpenter HM; Hendricks JD; Pereira CB; Williams DE
    Environ Health Perspect; 2008 Aug; 116(8):1047-55. PubMed ID: 18709148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluorooctanoic acid has persistent effects on peroxisome proliferation and related parameters in mouse liver.
    Sohlenius AK; Lundgren B; DePierre JW
    J Biochem Toxicol; 1992; 7(4):205-12. PubMed ID: 1293309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of peroxisome proliferators on rat liver phospholipids: sphingomyelin degradation may be involved in hepatotoxic mechanism of perfluorodecanoic acid.
    Adinehzadeh M; Reo NV
    Chem Res Toxicol; 1998 May; 11(5):428-40. PubMed ID: 9585473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.